William Barton/iStock Editorial via Getty Images GSK ( NYSE: GSK ) shares jumped 8% Wednesday after the company announced it had reached agreements to settle roughly 93% of the U.S. liability cases filed in state court over the safety of its drug Zantac for up to $2.
2B. In a.
